Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Depreciation & Amortization (CF): 2017-2021

Historic Depreciation & Amortization (CF) for Cogent Biosciences (COGT) over the last 5 years, with Dec 2021 value amounting to $68,000.

  • Cogent Biosciences' Depreciation & Amortization (CF) rose 300.00% to $68,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $147,000, marking a year-over-year decrease of 79.58%. This contributed to the annual value of $2.5 million for FY2024, which is 8.70% up from last year.
  • As of Q4 2021, Cogent Biosciences' Depreciation & Amortization (CF) stood at $68,000, which was up 41.67% from $48,000 recorded in Q3 2021.
  • In the past 5 years, Cogent Biosciences' Depreciation & Amortization (CF) ranged from a high of $352,000 in Q4 2018 and a low of $14,000 during Q2 2021.
  • In the last 3 years, Cogent Biosciences' Depreciation & Amortization (CF) had a median value of $204,000 in 2020 and averaged $180,000.
  • Over the last 5 years, Cogent Biosciences' Depreciation & Amortization (CF) had its largest YoY gain of 300.00% in 2021, and its largest YoY loss of 95.10% in 2021.
  • Quarterly analysis of 5 years shows Cogent Biosciences' Depreciation & Amortization (CF) stood at $307,000 in 2017, then increased by 14.66% to $352,000 in 2018, then declined by 10.80% to $314,000 in 2019, then plummeted by 94.59% to $17,000 in 2020, then spiked by 300.00% to $68,000 in 2021.
  • Its Depreciation & Amortization (CF) was $68,000 in Q4 2021, compared to $48,000 in Q3 2021 and $14,000 in Q2 2021.